News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
785,200 Results
Type
Article (77793)
Company Profile (670)
Press Release (706737)
Multimedia
Podcasts (117)
Webinars (14)
Section
Business (211651)
Career Advice (3365)
Deals (37715)
Drug Delivery (124)
Drug Development (86974)
Employer Resources (175)
FDA (17258)
Job Trends (16720)
News (365026)
Policy (36024)
Tag
Academia (2993)
Academic (2)
Accelerated approval (6)
Adcomms (26)
Allergies (96)
Alliances (52964)
ALS (103)
Alzheimer's disease (1496)
Antibody-drug conjugate (ADC) (150)
Approvals (17225)
Artificial intelligence (301)
Autoimmune disease (27)
Automation (16)
Bankruptcy (355)
Best Places to Work (12601)
BIOSECURE Act (21)
Biosimilars (117)
Biotechnology (460)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (310)
Cancer (2441)
Cardiovascular disease (200)
Career advice (2848)
Career pathing (34)
CAR-T (174)
Cell therapy (484)
Cervical cancer (22)
Clinical research (70202)
Collaboration (926)
Company closure (2)
Compensation (576)
Complete response letters (28)
COVID-19 (2831)
CRISPR (48)
C-suite (274)
Cystic fibrosis (109)
Data (2360)
Decentralized trials (2)
Denatured (35)
Depression (53)
Diabetes (288)
Diagnostics (6866)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (132)
Drug pricing (125)
Drug shortages (31)
Duchenne muscular dystrophy (102)
Earnings (82422)
Editorial (45)
Employer branding (21)
Employer resources (150)
Events (123781)
Executive appointments (788)
FDA (18680)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (823)
Gene editing (122)
Generative AI (26)
Gene therapy (351)
GLP-1 (816)
Government (5006)
Grass and pollen (6)
Guidances (150)
Healthcare (20810)
Huntington's disease (23)
IgA nephropathy (31)
Immunology and inflammation (142)
Indications (30)
Infectious disease (2992)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (102)
Interviews (635)
IPO (17670)
IRA (51)
Job creations (4602)
Job search strategy (2376)
Kidney cancer (10)
Labor market (42)
Layoffs (558)
Leadership (23)
Legal (8537)
Liver cancer (80)
Lung cancer (340)
Lymphoma (158)
Machine learning (9)
Management (62)
Manufacturing (358)
MASH (79)
Medical device (14526)
Medtech (14531)
Mergers & acquisitions (20659)
Metabolic disorders (764)
Multiple sclerosis (88)
NASH (21)
Neurodegenerative disease (111)
Neuropsychiatric disorders (32)
Neuroscience (2097)
NextGen: Class of 2025 (7561)
Non-profit (5071)
Now hiring (37)
Obesity (400)
Opinion (273)
Ovarian cancer (82)
Pain (105)
Pancreatic cancer (90)
Parkinson's disease (161)
Partnered (22)
Patents (254)
Patient recruitment (119)
Peanut (51)
People (63601)
Pharmaceutical (138)
Pharmacy benefit managers (20)
Phase I (21744)
Phase II (30585)
Phase III (22970)
Pipeline (1381)
Policy (172)
Postmarket research (3229)
Preclinical (9847)
Press Release (71)
Prostate cancer (113)
Psychedelics (36)
Radiopharmaceuticals (268)
Rare diseases (424)
Real estate (7056)
Recruiting (70)
Regulatory (24816)
Reports (40)
Research institute (2646)
Resumes & cover letters (518)
Rett syndrome (5)
RNA editing (5)
RSV (48)
Schizophrenia (80)
Series A (143)
Series B (94)
Service/supplier (27)
Sickle cell disease (59)
Special edition (19)
Spinal muscular atrophy (163)
Sponsored (33)
Startups (3931)
State (2)
Stomach cancer (14)
Supply chain (75)
Tariffs (51)
The Weekly (80)
Vaccines (796)
Venture capitalists (44)
Weight loss (272)
Women's health (36)
Worklife (20)
Date
Last 7 days (983)
Last 30 days (3128)
Last 365 days (34617)
2025 (12467)
2024 (37617)
2023 (42362)
2022 (53778)
2021 (58584)
2020 (57558)
2019 (51156)
2018 (38858)
2017 (35502)
2016 (35579)
2015 (41852)
2014 (35838)
2013 (33472)
2012 (33738)
2011 (33836)
2010 (33215)
Location
Africa (1103)
Alabama (61)
Alaska (7)
Arizona (236)
Arkansas (14)
Asia (46042)
Australia (8279)
California (6649)
Canada (2096)
China (570)
Colorado (286)
Connecticut (307)
Delaware (166)
Europe (106983)
Florida (977)
Georgia (226)
Hawaii (1)
Idaho (62)
Illinois (621)
India (30)
Indiana (340)
Iowa (11)
Japan (176)
Kansas (113)
Kentucky (28)
Louisiana (15)
Maine (70)
Maryland (990)
Massachusetts (5092)
Michigan (248)
Minnesota (431)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (69)
New Hampshire (70)
New Jersey (1875)
New Mexico (31)
New York (1873)
North Carolina (1146)
North Dakota (9)
Northern California (2873)
Ohio (224)
Oklahoma (15)
Oregon (48)
Pennsylvania (1465)
Puerto Rico (14)
Rhode Island (36)
South America (1457)
South Carolina (26)
South Dakota (1)
Southern California (2482)
Tennessee (108)
Texas (996)
United States (25387)
Utah (199)
Virginia (176)
Washington D.C. (71)
Washington State (616)
West Virginia (3)
Wisconsin (72)
785,200 Results for "tisch ms research center of new york".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
First FDA-Approved Phase II Stem Cell Treatment Study Shows Significant Improvements in Progressive MS Patients
The Tisch MS Research Center of New York, the world’s largest MS research center, has announced publication of the results of its FDA-approved Phase II stem cell treatment study in a leading stem cell journal, Stem Cell Research & Therapy.
June 5, 2024
·
4 min read
Pharm Country
Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace
The Tisch Multiple Sclerosis Research Center of New York, the world’s largest independent research center focusing on MS, is proud to announce that its FDA-approved stem cell treatment study was featured in an article in BioSpace.
June 29, 2022
·
1 min read
Job Trends
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
November 21, 2024
·
1 min read
·
Chantal Dresner
Press Releases
New York Cancer & Blood Specialists Adopt the DeepScribe Ambient Operating System for Oncology
April 22, 2025
·
4 min read
Press Releases
Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma
April 29, 2025
·
8 min read
Press Releases
NYU Langone Sets the Standard for Highest Quality Pediatric Kidney and Liver Transplant Programs in New York
May 2, 2025
·
4 min read
Press Releases
Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
April 30, 2025
·
1 min read
Press Releases
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th
April 4, 2025
·
9 min read
Business
Lynx.MD Partners with New York Gastroenterology Associates to Enhance Gastrointestinal Research Efforts
Committed to advancing gastrointestinal research, Lynx.MD, the industry-leading medical data intelligence platform tailored specifically for the gastroenterology market, announces its collaboration with New York Gastroenterology Associates.
May 15, 2024
·
3 min read
BioMidwest
Valent BioSciences Opens New State-of-the-Art Addition at Melnik and Shafer Biorational Research Center
Valent BioSciences celebrated the grand opening of the new Venburg Wing at the company’s Melnik and Shafer Biorational Research Center in Libertyville, Illinois, during a special ceremony.
May 29, 2024
·
3 min read
1 of 78,520
Next
